Wow the biotech version of a soap opera? It sounds like quite the mess.
How has the dozil shortage impacted ZIOP? NKTR has claimed they could not recruit their 102 trial because of that (patients failing was an entry criteria) which I am not fully convinced of because when enrollment was expanded they claimed it would be rapidly enrolled.
Market Data 
Markets 
AI
